Does DUVELISIB Cause Thrombocytopenia? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Thrombocytopenia have been filed in association with DUVELISIB (COPIKTRA). This represents 0.7% of all adverse event reports for DUVELISIB.
5
Reports of Thrombocytopenia with DUVELISIB
0.7%
of all DUVELISIB reports
3
Deaths
3
Hospitalizations
How Dangerous Is Thrombocytopenia From DUVELISIB?
Of the 5 reports, 3 (60.0%) resulted in death, 3 (60.0%) required hospitalization.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for DUVELISIB.
What Other Side Effects Does DUVELISIB Cause?
Product use in unapproved indication (162)
Diarrhoea (110)
Death (89)
Fatigue (75)
Prescribed underdose (63)
Off label use (57)
Nausea (49)
Pneumonia (40)
Pyrexia (40)
Malignant neoplasm progression (38)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which DUVELISIB Alternatives Have Lower Thrombocytopenia Risk?
DUVELISIB vs DYDROGESTERONE
DUVELISIB vs EBASTINE
DUVELISIB vs ECALLANTIDE
DUVELISIB vs ECONAZOLE
DUVELISIB vs ECULIZUMAB